$EMMA
Emmaus Life Sciences, Inc. Stock $emma

$emma Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-Q Financial Statement

#000156459021056658 Filed on November 12, 2021

Income Statement

Concept	2021 Q3	2020 Q3	2020 Q2
Revenue	$5.766M	$5.601M	$4.360M
YoY Change	2.95%	-2.76%	-20.63%
Cost Of Revenue	$445.0K	$484.0K	$446.0K
YoY Change	-8.06%	95.16%	68.94%
Gross Profit	$5.321M	$5.117M	$3.914M
YoY Change	3.99%	-7.17%	-25.15%
Gross Profit Margin	92.28%	91.36%	89.77%
Selling, General & Admin	$4.882M	$4.480M	$4.860M
YoY Change	8.97%	-49.29%	6.28%
% of Gross Profit	91.75%	87.55%	124.17%
Research & Development	$470.0K	$629.0K	$589.0K
YoY Change	-25.28%	-13.24%	9.07%
% of Gross Profit	8.83%	12.29%	15.05%
Depreciation & Amortization	$11.00K	$12.00K	$11.00K
YoY Change	-8.33%	-25.0%	-21.43%
% of Gross Profit	0.21%	0.23%	0.28%
Operating Expenses	$5.352M	$5.109M	$5.449M
YoY Change	4.76%	-46.55%	6.57%
Operating Profit	-$31.00K	$8.000K	-$1.535M
YoY Change	-487.5%	-100.2%	-1423.28%
Interest Expense	-$3.080M	$1.606M	$1.309M
YoY Change	-291.78%	-81.57%	-83.28%
% of Operating Profit		20075.0%
Other Income/Expense, Net	$192.0K	$718.0K	$567.0K
YoY Change	-73.26%	-103.2%
Pretax Income	-$2.919M	$5.878M	-$9.972M
YoY Change	-149.66%	-132.06%	-43.16%
Income Tax	$232.0K	$293.0K	-$500.0K
% Of Pretax Income		4.98%
Net Earnings	-$3.151M	$5.585M	-$9.473M
YoY Change	-156.42%	-130.37%	-46.16%
Net Earnings / Revenue	-54.65%	99.71%	-217.27%
Basic Earnings Per Share	-$0.06
Diluted Earnings Per Share	-$63.90K	$114.0K	-$193.4K
COMMON SHARES
Basic Shares Outstanding	49.31M		48.99M
Diluted Shares Outstanding	49.31M

Balance Sheet

Concept	2021 Q3	2020 Q3	2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.321M	$4.949M	$28.04M
YoY Change	-53.1%	-87.98%	1047.54%
Cash & Equivalents	$2.321M	$4.949M	$1.032M
Short-Term Investments		$0.00	$27.01M
Other Short-Term Assets	$250.0K	$572.0K	$899.0K
YoY Change	-56.29%	-25.42%	492.62%
Inventory	$6.252M	$7.422M	$7.863M
Prepaid Expenses	$242.0K
Receivables	$2.663M	$1.726M	$1.457M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$12.47M	$40.89M	$38.54M
YoY Change	-69.5%	2.28%	-13.64%
LONG-TERM ASSETS
Property, Plant & Equipment	$97.00K	$130.0K	$141.0K
YoY Change	-25.38%	-20.25%	-2.76%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$43.55M	$14.48M	$13.01M
YoY Change	200.68%
Other Assets	$293.0K	$291.0K	$285.0K
YoY Change	0.69%	-31.85%	-98.42%
Total Long-Term Assets	$47.58M	$19.05M	$17.71M
YoY Change	149.78%	5.16%	-2.71%
TOTAL ASSETS
Total Short-Term Assets	$12.47M	$40.89M	$38.54M
Total Long-Term Assets	$47.58M	$19.05M	$17.71M
Total Assets	$60.06M	$59.94M	$56.25M
YoY Change	0.19%	3.18%	-10.47%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.822M	$2.173M	$6.021M
YoY Change	-16.15%	-70.64%	972.31%
Accrued Expenses	$4.654M	$4.932M	$3.703M
YoY Change	-5.64%	101.64%	211.99%
Deferred Revenue
YoY Change
Short-Term Debt	$7.733M	$1.616M	$634.0K
YoY Change	378.53%	737.31%
Long-Term Debt Due	$3.269M	$10.66M	$11.87M
YoY Change	-69.34%	-40.15%	790900.0%
Total Short-Term Liabilities	$25.03M	$23.78M	$26.48M
YoY Change	5.24%	-24.2%	-60.15%
LONG-TERM LIABILITIES
Long-Term Debt	$14.41M	$3.505M	$3.638M
YoY Change	311.07%	192.08%	489.91%
Other Long-Term Liabilities	$32.28M	$35.44M	$36.43M
YoY Change	-8.92%	2.55%	3.12%
Total Long-Term Liabilities	$32.28M	$42.53M	$36.43M
YoY Change	-24.11%	7.67%	3.12%
TOTAL LIABILITIES
Total Short-Term Liabilities	$25.03M	$23.78M	$26.48M
Total Long-Term Liabilities	$32.28M	$42.53M	$36.43M
Total Liabilities	$75.16M	$66.31M	$70.27M
YoY Change	13.35%	-5.74%	-33.7%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$15.10M	-$6.365M	-$14.02M
YoY Change
Total Liabilities & Shareholders Equity	$60.06M	$59.94M	$56.25M
YoY Change	0.19%	3.18%	-10.47%

Cashflow Statement

Concept	2021 Q3	2020 Q3	2020 Q2
OPERATING ACTIVITIES
Net Income	-$3.151M	$5.585M	-$9.473M
YoY Change	-156.42%	-130.37%	-46.16%
Depreciation, Depletion And Amortization	$11.00K	$12.00K	$11.00K
YoY Change	-8.33%	-25.0%	-21.43%
Cash From Operating Activities	$1.640M	-$2.643M	-$1.719M
YoY Change	-162.05%	-378.77%	-21.51%
INVESTING ACTIVITIES
Capital Expenditures	-$10.00K	$0.00	-$13.00K
YoY Change		-100.0%	11.11%
Acquisitions
YoY Change
Other Investing Activities	-$1.276M	$31.76M	$1.569M
YoY Change	-104.02%	-2336.48%
Cash From Investing Activities	-$1.286M	$31.76M	$1.556M
YoY Change	-104.05%	-2283.88%	-13399.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	300.0K	482.0K	-560.0K
YoY Change	-37.76%	-121.83%	-116.27%
NET CHANGE
Cash From Operating Activities	1.640M	-2.643M	-1.719M
Cash From Investing Activities	-1.286M	31.76M	1.556M
Cash From Financing Activities	300.0K	482.0K	-560.0K
Net Change In Cash	654.0K	29.60M	-723.0K
YoY Change	-97.79%	-1190.65%	-158.3%
FREE CASH FLOW
Cash From Operating Activities	$1.640M	-$2.643M	-$1.719M
Capital Expenditures	-$10.00K	$0.00	-$13.00K
Free Cash Flow	$1.650M	-$2.643M	-$1.706M
YoY Change	-162.43%	-369.06%	-21.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q3	emma	Common Stock Purchase Period CommonStockPurchasePeriod	P5Y
CY2020Q3	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	6464000
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	-15101000
CY2021Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	93000
CY2021Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-2754000
CY2021Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	86000
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3151000
	us-gaap	Equity Securities Fv Ni Realized Gain Loss EquitySecuritiesFvNiRealizedGainLoss	7672000
CY2021Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.06
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.11
CY2021Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	500000
CY2021Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	181000
CY2021Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	58000
CY2021Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	165000
CY2021Q1	us-gaap	Net Income Loss NetIncomeLoss	-8422000
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	-12676000
CY2021Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	274000
CY2021Q2	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	546000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-11053000
CY2020Q1	emma	Fair Value Of Warrants Including Down Round Protection Adjustments FairValueOfWarrantsIncludingDownRoundProtectionAdjustments	400000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	142000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	209000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	61000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	5509000
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	-4732000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	219000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-33000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	-9473000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	-14019000
CY2020Q3	emma	Fair Value Of Warrants Including Down Round Protection Adjustments FairValueOfWarrantsIncludingDownRoundProtectionAdjustments	1983000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	121000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-35000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	5585000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	-6365000
	us-gaap	Profit Loss ProfitLoss	-9084000
	us-gaap	Profit Loss ProfitLoss	1621000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	45000
	emma	Inventory Reserve InventoryReserve	-423000
	emma	Inventory Reserve InventoryReserve	-596000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1410000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3200000
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-1415000
	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	316000
	emma	Equity Securities Fv Ni Realized Gain Loss Excluding Impairment Loss EquitySecuritiesFvNiRealizedGainLossExcludingImpairmentLoss	7672000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1999000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1474000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1172000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-1425000
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1000
	us-gaap	Share Based Compensation ShareBasedCompensation	548000
	us-gaap	Share Based Compensation ShareBasedCompensation	549000
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	500000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	-322000
	emma	Gain Loss On Warrant Derivative Liabilities GainLossOnWarrantDerivativeLiabilities	669000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	-1132000
	emma	Gain Loss On Conversion Feature Derivative Note Payable GainLossOnConversionFeatureDerivativeNotePayable	51000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2469000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-425000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-404000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	44000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-202000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-336000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-417000
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-313000
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	15000
	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-43000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-173000
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3119000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	242000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-3883000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-637000
	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	1451000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2119000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-4362000
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	35601000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	13000
	emma	Loan To Equity Method Investee LoanToEquityMethodInvestee	-5241000
	emma	Loan To Equity Method Investee LoanToEquityMethodInvestee	-2274000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5252000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	33314000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1000000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1980000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	14490000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1079000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	200000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	7200000
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	2000000
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	142000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	7211000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-78000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-6000
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-14000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-166000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	28860000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2487000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1769000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2321000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30629000
	us-gaap	Interest Paid Net InterestPaidNet	840000
	us-gaap	Interest Paid Net InterestPaidNet	1543000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	43000
	us-gaap	Income Taxes Paid IncomeTaxesPaid	126000
	emma	Debt Discount Due To Conversion Of Features Derivative DebtDiscountDueToConversionOfFeaturesDerivative	5555000
	emma	Debt Discounts Due To Warrant Issued With Debt DebtDiscountsDueToWarrantIssuedWithDebt	3808000
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2321000
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4949000
CY2020Q3	us-gaap	Restricted Cash Current RestrictedCashCurrent	25680000
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2321000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	30629000
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	23276594
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	19276395
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5766000
CY2020Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5601000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	17590000
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	16915000
CY2020Q4	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	2726000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	5189000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	90000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	3438000
CY2021Q3	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	4387000
CY2019Q4	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	1897000
	emma	Revenue Allowance And Accrual Activities Provision Related To Sales In Current Year RevenueAllowanceAndAccrualActivitiesProvisionRelatedToSalesInCurrentYear	5203000
	emma	Revenue Allowance And Accrual Activities Adjustments Related To Prior Period Sales RevenueAllowanceAndAccrualActivitiesAdjustmentsRelatedToPriorPeriodSales	93000
	emma	Revenue Allowance And Accrual Activities Credit And Payments Made RevenueAllowanceAndAccrualActivitiesCreditAndPaymentsMade	3906000
CY2020Q3	emma	Revenue Allowance And Accrual Activities RevenueAllowanceAndAccrualActivities	3101000
CY2021Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1472000
CY2020Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	1486000
CY2020Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1184000
CY2021Q3	us-gaap	Inventory Net InventoryNet	6252000
CY2020Q4	us-gaap	Inventory Net InventoryNet	7087000
CY2021Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	70000
CY2020Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	721000
CY2021Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6317000
CY2020Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	6064000
CY2021Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1607000
CY2021Q3	us-gaap	Prepaid Insurance PrepaidInsurance	167000
CY2020Q4	us-gaap	Prepaid Insurance PrepaidInsurance	388000
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	242000
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	454000
CY2021Q3	emma	Due From Equity Method Investee Current DueFromEquityMethodInvesteeCurrent	579000
CY2020Q4	emma	Due From Equity Method Investee Current DueFromEquityMethodInvesteeCurrent	376000
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	250000
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	267000
CY2021Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1238000
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1485000
CY2021Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	480000
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	485000
CY2021Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	383000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	365000
CY2021Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	97000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	120000
CY2021Q3	us-gaap	Depreciation Depreciation	11000
CY2020Q3	us-gaap	Depreciation Depreciation	12000
	us-gaap	Depreciation Depreciation	34000
	us-gaap	Depreciation Depreciation	35000
CY2020Q3	us-gaap	Debt Instrument Call Date Earliest DebtInstrumentCallDateEarliest	2020-09-28
CY2021Q3	emma	Cro Expenses CROExpenses	443000
CY2020Q4	emma	Cro Expenses CROExpenses	262000
CY2021Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	552000
CY2020Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	252000
CY2021Q3	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	508000
CY2020Q4	us-gaap	Accrued Sales Commission Current AccruedSalesCommissionCurrent	395000
CY2021Q3	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	253000
CY2020Q4	emma	Accrued Manufacturing Expenses Current AccruedManufacturingExpensesCurrent	596000
CY2021Q3	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	66000
CY2020Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	518000
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1822000
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2023000
CY2021Q3	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	79000
CY2020Q4	emma	Interest Payable Related Parties Current InterestPayableRelatedPartiesCurrent	41000
CY2021Q3	us-gaap	Interest Payable Current InterestPayableCurrent	418000
CY2020Q4	us-gaap	Interest Payable Current InterestPayableCurrent	627000
CY2021Q3	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1067000
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1053000
CY2021Q3	emma	Accrued Government Rebates And Other Rebates Current AccruedGovernmentRebatesAndOtherRebatesCurrent	2553000
CY2020Q4	emma	Accrued Government Rebates And Other Rebates Current AccruedGovernmentRebatesAndOtherRebatesCurrent	2659000
CY2021Q3	emma	Due To Equity Method Investee Current DueToEquityMethodInvesteeCurrent	480000
CY2020Q4	emma	Due To Equity Method Investee Current DueToEquityMethodInvesteeCurrent	545000
CY2021Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	554000
CY2020Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	512000
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4654000
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4769000
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	6973000
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	7460000
	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	10122974
CY2020Q4	emma	Debt Instrument Principal Outstanding Amount DebtInstrumentPrincipalOutstandingAmount	15294000
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	1720000
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	4940000
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2706000
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	32275000
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	34470000
CY2021Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	4732000
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	18077000
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	13574000
CY2020	us-gaap	Debt Instrument Convertible Number Of Equity Instruments DebtInstrumentConvertibleNumberOfEquityInstruments	3946723
CY2021Q3	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.05
CY2020Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.10
CY2021Q3	emma	Debt Weighted Average Effective Interest Rate DebtWeightedAverageEffectiveInterestRate	0.14
CY2020Q4	emma	Debt Weighted Average Effective Interest Rate DebtWeightedAverageEffectiveInterestRate	0.37
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	3447000
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	222000
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4650000
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	14490000
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	22809000
CY2020Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10
CY2020Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-04-21
CY2020Q1	emma	Convertible Debentures Conversion Price ConvertibleDebenturesConversionPrice	3.00
CY2020Q1	emma	Convertible Debentures Conversion Price ConvertibleDebenturesConversionPrice	9.52
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.00
CY2020Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	5.87
CY2020Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.00
CY2021Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	8236017
CY2021Q3	emma	Warrants Exercisable WarrantsExercisable	6986017
	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y6M
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	232000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	58000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	293000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	80000
	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0
CY2021Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2021Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	300000
CY2020Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	286000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	889000
	us-gaap	Operating Lease Expense OperatingLeaseExpense	895000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	290000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1174000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1058000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1063000
CY2021Q3	emma	Lessee Operating Leases Liability Payments Due Year Four And Thereafter LesseeOperatingLeasesLiabilityPaymentsDueYearFourAndThereafter	1928000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	5513000
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1346000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4167000
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3600000
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	4200000
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y9M18D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.116

Files In Submission

Name	View Source	Status
0001564590-21-056658-index-headers.html	Edgar Link	pending
0001564590-21-056658-index.html	Edgar Link	pending
0001564590-21-056658.txt	Edgar Link	pending
0001564590-21-056658-xbrl.zip	Edgar Link	pending
emma-10q_20210930.htm	Edgar Link	pending
emma-10q_20210930_htm.xml	Edgar Link	completed
emma-20210930.xsd	Edgar Link	pending
emma-20210930_cal.xml	Edgar Link	unprocessable
emma-20210930_def.xml	Edgar Link	unprocessable
emma-20210930_lab.xml	Edgar Link	unprocessable
emma-20210930_pre.xml	Edgar Link	unprocessable
emma-ex311_8.htm	Edgar Link	pending
emma-ex312_7.htm	Edgar Link	pending
emma-ex321_9.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$EMMA
Emmaus Life Sciences, Inc. Stock $emma

2021 Q3 Form 10-Q Financial Statement

#000156459021056658 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EMMA Emmaus Life Sciences, Inc. Stock $emma

2021 Q3 Form 10-Q Financial Statement

#000156459021056658 Filed on November 12, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$EMMA
Emmaus Life Sciences, Inc. Stock $emma